Company Data

Cognition Therapeutics Inc.

Ticker
CGTX
Current Price
$0.5832 -4.33%
Market Cap
$24.2M
Price Target
Refer to Report
Volume
501.5K
52wk Range
$0.34 - $2.95
Advanced Market Data

Overview

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy